Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
BlackRock Health Sciences Term Trust's 3-Year RORE % for the quarter that ended in Dec. 2025 was -111.84%.
BMEZ's 3-Year RORE % is ranked worse than 90.28% of 1533
companies
in the Asset Management industry
Industry Median: 12.5
vs BMEZ: -111.84
BlackRock Health Sciences Term Trust (NYSE:BMEZ) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
BlackRock Health Sciences Term Trust 3-Year RORE % Related Terms
BlackRock Health Sciences Term Trust 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BlackRock Health Sciences Term Trust 3-Year RORE % Chart
For the Asset Management subindustry, BlackRock Health Sciences Term Trust's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BlackRock Health Sciences Term Trust 3-Year RORE % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, BlackRock Health Sciences Term Trust's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where BlackRock Health Sciences Term Trust's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.
BlackRock Health Sciences Term Trust (BMEZ) has a 3-Year RORE % of -111.84 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on BlackRock Health Sciences Term Trust and its competitors. According to the industry distribution chart, BlackRock Health Sciences Term Trust ranks #1384 out of 1533 companies in the Asset Management industry, placing it in the top 90.3%.
Is BlackRock Health Sciences Term Trust's 3-Year RORE % too high?
BlackRock Health Sciences Term Trust's current 3-Year RORE % is -111.84. Based on the distribution chart, BlackRock Health Sciences Term Trust ranks #1384 out of 1533 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, BlackRock Health Sciences Term Trust has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BlackRock Health Sciences Term Trust's 3-Year RORE % compare to BTZ and AIO?
According to the Asset Management industry distribution chart, BlackRock Health Sciences Term Trust ranks #1384 out of 1533 companies for 3-Year RORE %. This places BlackRock Health Sciences Term Trust in the lower half of its industry. The industry median 3-Year RORE % is 12.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for an Asset Management company?
The median 3-Year RORE % among Asset Management companies is 12.50, based on 1,533 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on BlackRock Health Sciences Term Trust and its competitors. For the Asset Management industry, the median 3-Year RORE % is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BlackRock Health Sciences Term Trust's current 3-Year RORE % is -111.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BlackRock Health Sciences Term Trust stock overvalued right now?
BlackRock Health Sciences Term Trust (BMEZ) has a current 3-Year RORE % of -111.84. The current 3-Year RORE % is -111.84. BlackRock Health Sciences Term Trust's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For BlackRock Health Sciences Term Trust (BMEZ), the current 3-Year RORE % is -111.84 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BlackRock Health Sciences Term Trust Business Description
BlackRock Health Sciences Term Trust is a closed-end fund focused on the healthcare and health sciences sector. Its investment objectives are to provide total return and income through long-term capital appreciation.
36GF Score
Get the complete analysis for BMEZ
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMEZ has been successfully added to your 
